Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide

Molecular Immunology

Volumn 59, Issue 1, 2014, Pages 55-63

  Bommineni, Yugendar R ^a,b   Pham, Giang H ^a,c   Sunkara, Lakshmi T ^a   Achanta, Mallika ^a   Zhang, Guolong ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b Virginia Department of Agriculture and Consumer Services   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Adjuvant; Antimicrobial peptides; Antimicrobial resistance; Host defense peptides; Immunomodulation; MRSA

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CATHELICIDIN; CHEMOKINE; FOWLICIDIN 1; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNIZATION; IMMUNOMODULATION; MACROPHAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL;

ADJUVANT; ANTIMICROBIAL PEPTIDES; ANTIMICROBIAL RESISTANCE; HOST DEFENSE PEPTIDES; IMMUNOMODULATION; MRSA;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGENS, CD86; ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; CELL LINE; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOTAXIS; CHICKENS; DISEASE RESISTANCE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MACROPHAGES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEPTIDE FRAGMENTS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS;

EID: 84893504946     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.01.004     Document Type: Article

References (44)

1. Achanta M., Sunkara L.T., Dai G., Bommineni Y.R., Jiang W., Zhang G. Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides. Journal of Animal Science and Biotechnology 2012, 3:15.
2. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
3. Bommineni Y.R., Achanta M., Alexander J., Sunkara L.T., Ritchey J.W., Zhang G. A fowlicidin-1 analog protects mice from lethal infections induced by methicillin-resistant Staphylococcus aureus. Peptides 2010, 31:1225-1230.
4. Bommineni Y.R., Dai H., Gong Y.X., Soulages J.L., Fernando S.C., Desilva U., Prakash O., Zhang G. Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities. FEBS Journal 2007, 274:418-428.
5. Brown K.L., Hancock R.E. Cationic host defense (antimicrobial) peptides. Current Opinion in Immunology 2006, 18:24-30.
6. Campbell J.J., Qin S., Bacon K.B., Mackay C.R., Butcher E.C. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. Journal of Cell Biology 1996, 134:255-266.
7. Choi K.Y., Chow L.N., Mookherjee N. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. Journal of Innate Immunity 2012, 4:361-370.
8. Fjell C.D., Hiss J.A., Hancock R.E., Schneider G. Designing antimicrobial peptides: form follows function. Nature Reviews Drug Discovery 2012, 11:37-51.
9. Funderburg N., Lederman M.M., Feng Z., Drage M.G., Jadlowsky J., Harding C.V., Weinberg A., Sieg S.F. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:18631-18635.
10. Funderburg N.T., Jadlowsky J.K., Lederman M.M., Feng Z., Weinberg A., Sieg S.F. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human beta-defensin-3 differentially induce interleukin-10 and nuclear factor-kappaB signalling patterns in human monocytes. Immunology 2011, 134:151-160.
11. Hancock R.E., Nijnik A., Philpott D.J. Modulating immunity as a therapy for bacterial infections. Nature Reviews Microbiology 2012, 10:243-254.
12. Hempel S.L., Buettner G.R., O'Malley Y.Q., Wessels D.A., Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radical Biology & Medicine 1999, 27:146-159.
13. Kindrachuk J., Jenssen H., Elliott M., Townsend R., Nijnik A., Lee S.F., Gerdts V., Babiuk L.A., Halperin S.A., Hancock R.E. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 2009, 27:4662-4671.
14. Kovacs-Nolan J., Mapletoft J.W., Latimer L., Babiuk L.A., Hurk S. CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 2009, 27:2048-2054.
15. Labro M.T., Ollivier V., Babin-Chevaye C. Interaction of rifalazil with oxidant-generating systems of human polymorphonuclear neutrophils. Antimicrobial Agents and Chemotherapy 2005, 49:5018-5023.
16. Lee H.Y., Bae Y.S. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor. Biochemical and Biophysical Research Communications 2008, 369:573-578.
17. Lisanby M.W., Swiecki M.K., Dizon B.L., Pflughoeft K.J., Koehler T.M., Kearney J.F. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. Journal of Immunology 2008, 181:4989-5000.
18. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., Roche F.M., Mu R., Doho G.H., Pistolic J., Powers J.P., Bryan J., Brinkman F.S., Hancock R.E. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. Journal of Immunology 2006, 176:2455-2464.
19. Mookherjee N., Lippert D.N., Hamill P., Falsafi R., Nijnik A., Kindrachuk J., Pistolic J., Gardy J., Miri P., Naseer M., Foster L.J., Hancock R.E. Intracellular receptor for human host defense peptide LL-37 in monocytes. Journal of Immunology 2009, 183:2688-2696.
20. Nicholls E.F., Madera L., Hancock R.E. Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Annals of the New York Academy of Sciences 2010, 1213:46-61.
21. Nijnik A., Madera L., Ma S., Waldbrook M., Elliott M.R., Easton D.M., Mayer M.L., Mullaly S.C., Kindrachuk J., Jenssen H., Hancock R.E. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. Journal of Immunology 2010, 184:2539-2550.
22. Niyonsaba F., Madera L., Afacan N., Okumura K., Ogawa H., Hancock R.E. The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions. Journal of Leukocyte Biology 2013, 94:159-170.
23. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., Nagaoka I., Okumura K., Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. Journal of Investigative Dermatology 2007, 127:594-604.
24. Okuyama-Nishida Y., Akiyama N., Sugimori G., Nomura K., Ogawa K., Homma K.J., Sekimizu K., Tsujimoto M., Natori S. Prevention of death in bacterium-infected mice by a synthetic antimicrobial peptide, L5, through activation of host immunity. Antimicrobial Agents and Chemotherapy 2009, 53:2510-2516.
25. Perricone C., Colafrancesco S., Mazor R.D., Soriano A., Agmon-Levin N., Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. Journal of Autoimmunity 2013, 47:1-16.
26. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. Journal of Immunology 2010, 184:6688-6694.
27. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Journal of Immunology 2002, 169:3883-3891.
28. Scott M.G., Dullaghan E., Mookherjee N., Glavas N., Waldbrook M., Thompson A., Wang A., Lee K., Doria S., Hamill P., Yu J.J., Li Y., Donini O., Guarna M.M., Finlay B.B., North J.R., Hancock R.E. An anti-infective peptide that selectively modulates the innate immune response. Nature Biotechnology 2007, 25:465-472.
29. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nature Immunology 2005, 6:551-557.
30. Semple F., Dorin J.R. Beta-defensins: multifunctional modulators of infection, inflammation and more?. Journal of Innate Immunity 2012, 4:337-348.
31. Steinstraesser L., Kraneburg U., Jacobsen F., Al-Benna S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011, 216:322-333.
32. Summers C., Rankin S.M., Condliffe A.M., Singh N., Peters A.M., Chilvers E.R. Neutrophil kinetics in health and disease. Trends in Immunology 2010, 31:318-324.
33. Takahashi D., Shukla S.K., Prakash O., Zhang G. Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie 2010, 92:1236-1241.
34. Xiao Y., Cai Y., Bommineni Y.R., Fernando S.C., Prakash O., Gilliland S.E., Zhang G. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. Journal of Biological Chemistry 2006, 281:2858-2867.
35. Xiao Y., Dai H., Bommineni Y.R., Soulages J.L., Gong Y.X., Prakash O., Zhang G. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS Journal 2006, 273:2581-2593.
36. Xiao Y., Herrera A.I., Bommineni Y.R., Soulages J.L., Prakash O., Zhang G. The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization. Journal of Innate Immunity 2009, 1:268-280.
37. Yang D., Biragyn A., Hoover D.M., Lubkowski J., Oppenheim J.J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annual Review of Immunology 2004, 22:181-215.
38. Yang J., Mao M., Zhang S., Li H., Jiang Z., Cao G., Cao D., Wang X., Zhang L. Innate defense regulator peptide synergizes with CpG ODN for enhanced innate intestinal immune responses in neonate piglets. International Immunopharmacology 2012, 12:415-424.
39. Yau W.M., Wimley W.C., Gawrisch K., White S.H. The preference of tryptophan for membrane interfaces. Biochemistry 1998, 37:14713-14718.
40. Yona S., Jung S. Monocytes: subsets, origins, fates and functions. Current Opinion in Hematology 2010, 17:53-59.
41. Yu H.B., Kielczewska A., Rozek A., Takenaka S., Li Y., Thorson L., Hancock R.E., Guarna M.M., North J.R., Foster L.J., Donini O., Finlay B.B. Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. Journal of Biological Chemistry 2009, 284:36007-36011.
42. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. Journal of Leukocyte Biology 2004, 75:39-48.
43. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
44. Zeng X., Sunkara L.T., Jiang W., Bible M., Carter S., Ma X., Qiao S., Zhang G. Induction of porcine host defense Peptide gene expression by short-chain fatty acids and their analogs. PLoS One 2013, 8:e72922.